$
101. 06
-2.1
-2.0357%
Pre Market
$
+0.94 +0.9301% 102. 00
4.68B Market Cap
34.22 P/E Ratio
- Div Yield
602,320 Volume
3.96 Eps
$ 103.16
Previous Close 
Want to track HAE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Haemonetics Corporation (HAE) Statistics
Valuation metrics
Market Cap 4.68B
Enterprise value 5.63B
Trailing P/E (ttm) 49.96
Forward P/E -
PEG ratio -1.34
Price/Sales (ttm) 3.46
Price/Book (mrq) 5.58
Enterprise Value/Revenue 4.16
Enterprise Value/EBITDA 21.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 577.68K
Average volume (90 days) 844.87K
Price summary
52-Week low 47.32
52-Week high 109.57
Beta -
50-Day moving average 94.27
200-Day moving average 66.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 3 Dec 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 29.81
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.92
Total debt (mrq) -
Total Debt/Equity (mrq) 1.4
Current ratio (mrq) 3.08%
Book value per share (mrq) 18.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
